Back

Acute, low-grade inflammation elevates white matter sensitivity to ischemia

Mellor, A. G.; Harper, G. M.; Kelland, E. E.; Fern, R.

2026-01-08 neuroscience
10.64898/2026.01.07.698147 bioRxiv
Show abstract

AbstractIschemic brain injuries, including stroke, are highly prevalent neurological diseases. Acute, low-grade inflammation, often resulting from peripheral infection, is a recognised risk factor. White matter axons, and their supporting glia, are susceptible to both ischemic and neuroinflammatory injury. The mechanisms behind ischemic and severe inflammatory injury in white matter are well established. However, the white matter response to acute, low-grade inflammation, and how this can interact with co-morbidities such as cerebral ischemia are yet to be examined. Here, we examine the response of white matter to acute, low-grade inflammation and the downstream effects this had on sensitivity of ischemia. Ex vivo mouse optic nerve and corpus callosum, central white matter tracts, tolerated acute, low-grade inflammation (110-minutes, 0.1g/ml LPS), with preserved action potential conduction, limited microglial activation and no axo-myelinic damage. Exposure to these conditions elevated indicators of stress in oligodendrocytes which, when exposed to ischemic conditions (30 minutes oxygen-glucose deprivation), impaired their ability to maintain healthy myelin. There was a resulting increase in axo-myelinic damage and functional decline associated with ischemic conditions compared to white matter that had not been pre-exposed to LPS. Microglial depletion or dampening microglial responses with the clinically available drug minocycline eliminated the elevated sensitivity of white matter to ischemic injury associated with acute, low-grade inflammation. We demonstrate that acute, low-grade neuroinflammation primes white matter for heightened vulnerability to ischemic injury through microglial-mediated mechanisms. These findings provide a mechanistic explanation for the increased risk of ischemic brain injury observed during systemic inflammatory states and highlights microglial modulation as a clinical strategy to mitigate ischemic damage in susceptible patients.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Glia
81 papers in training set
Top 0.1%
56.2%
50% of probability mass above
2
Journal of Neuroinflammation
61 papers in training set
Top 0.3%
4.9%
3
Brain, Behavior, and Immunity
116 papers in training set
Top 0.5%
3.6%
4
Molecular Neurobiology
53 papers in training set
Top 0.4%
2.7%
5
iScience
1154 papers in training set
Top 10%
2.4%
6
Frontiers in Cellular Neuroscience
91 papers in training set
Top 0.7%
2.1%
7
Nature Communications
5641 papers in training set
Top 41%
2.1%
8
Cell Reports
1498 papers in training set
Top 22%
1.4%
9
Neurobiology of Disease
148 papers in training set
Top 2%
1.4%
10
Scientific Reports
3612 papers in training set
Top 64%
1.1%
11
Journal of Neurochemistry
53 papers in training set
Top 0.9%
1.1%
12
eLife
5828 papers in training set
Top 60%
1.0%
13
Nature Neuroscience
252 papers in training set
Top 5%
1.0%
14
The Journal of Neuroscience
1025 papers in training set
Top 9%
1.0%
15
Molecular Psychiatry
282 papers in training set
Top 5%
0.9%
16
Experimental Neurology
61 papers in training set
Top 1%
0.9%
17
Acta Neuropathologica Communications
89 papers in training set
Top 2%
0.9%
18
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 5%
0.9%
19
Journal of Cerebral Blood Flow & Metabolism
42 papers in training set
Top 0.6%
0.9%
20
British Journal of Pharmacology
40 papers in training set
Top 1%
0.6%
21
The FASEB Journal
194 papers in training set
Top 6%
0.6%
22
Developmental Cell
196 papers in training set
Top 5%
0.6%
23
Immunology
28 papers in training set
Top 0.8%
0.6%